THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST: National Clinical Analysis and Specialised Applications Team (NATCANSAT) is hosted by The Clatterbridge Cancer Centre NHSFT.

Data-sharing agreement from NHS Digital registers of approved data releases, 2014–2019. Evidence status: source reported.

Organisation: THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST
Source reference: DARS-NIC-14170-X2G3L-v0.9
Jurisdiction: England
Licence: Open Government Licence v3.0, subject to NHS England terms and exclusions

Register reference: DARS-NIC-14170-X2G3L-v0.9
Agreement period: not published to no end date published
For commercial purposes (as marked in the register): Not stated
Release files listed by NHS England: 21

Data approved

Hospital Episode Statistics Admitted Patient Care
Hospital Episode Statistics Accident and Emergency
Hospital Episode Statistics Outpatients
Office for National Statistics Mortality Data

Objective, as published

National Clinical Analysis and Specialised Applications Team (NATCANSAT) is hosted by The Clatterbridge Cancer Centre NHSFT. NATCANSAT supports a range of DH and NHS organisations involved with National Cancer and Cardiac Programs by providing detailed analysis as required with reference to specific diagnoses and/or procedures. Only individuals substantively employed by the Trust, working for NATCANSAT, have access to the data. Pseudonymised Data Wherever possible, analyses are undertaken using pseudonymised data but identifiers are necessary for different reasons. Unique Identifiers are required only for the linkage process, in order to generate pseudonymised datasets for further analysis. Careful consideration is always given to the use of identifiable data, and whether it is appropriate or necessary for the purpose. This approach alongside the wider availability of linked data sources has allowed NATCANSAT to limit its use of identifiable data very considerably in recent years. Pseudonymised and sensitive extracts are used to carry out analysis of hospital activity for a range of diagnosis and procedure codes, in order to support the objectives identified below. The extract contains all records to support work which compares affected patients with more general populations, or to provide denominators for complex analysis. Identifiable Data for Cancer/Cardiac Identifiable extracts are for patients identifiers for patients identified as having diagnoses or procedures which a…

Expected benefits, as published

Objective One • Policy Development NATCANSAT supports DH expert working groups and committees in their development of policy. Analysis of the HES (and linked) data benefits patients by facilitating evidence based decision making by these groups, where the policy being developed needs to include: o Numbers of patients and outcomes for specific patient cohorts o Volume of cases affected by a proposed change o Impact of the change in the service (cost/resources/travel times/critical mass etc) Example: DH Cardiovascular Strategy Supported by the analysis carried out by NATCANSAT, the committee developing the strategy made a number of recommendations regarding the improvement of diagnosis and treatment of Cardiovascular Disease, which will save lives, and improve the quality of life of survivo…

Source: https://webarchive.nationalarchives.gov.uk/ukgwa/2019/http://content.digital.nhs.uk/media/24614/Release-Register-March---May-2017/xls/Release_Register__March_-_May_20171.xlsx. Captured 2026-10-30.

Limitations: Agreement as recorded in an NHS Digital register of approved data releases (2014–2019), retrieved from the UK Government Web Archive. That register lists releases made in its period and the agreement's purpose statement as it then stood; it gives no agreement dates, and the agreement may have changed since. Imported only where a paper quotes a reference no current register holds.